Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Biological Psychiatry

• Publication date

  1982-02-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  PMID 7200378
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats.

  1980cited by this paper
• Decreased spiroperidol and LSD binding in rat brain after continuous amphetamine.

  1980cited by this paper
• Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine.

  1980cited by this paper
• Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia.

  1979cited by this paper
• Anomalous properties of [3H]spiperone binding sites in various areas of the rat limbic system.

  1979cited by this paper
• Presynaptic subsensitivity as a possible basis for sensitization by long-term dopamine mimetics.

  1979cited by this paper
• Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites.

  1979cited by this paper
• Amphetamine‐induced hypersensitivity in guinea pigs

  1979cited by this paper
• Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration.

  1978cited by this paper
• Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.

  1975cited by this paper
• An anatomy of schizophrenia?

  1973cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Opposite effects of neonatal hypoxia on acute amphetamine-induced hyperlocomotion in adult and adolescent mice.

  2013cites this paper
• GABAA receptors mediate the attenuating effects of a 5‐HT3 receptor antagonist on methamphetamine‐induced behavioral sensitization in mice

  2010cites this paper
• Dopamine neurotransmission is involved in the attenuating effects of 5‐HT3 receptor antagonist MDL 72222 on acute methamphetamine‐induced locomotor hyperactivity in mice

  2008influential citation
• Desipramine attenuates working memory impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex

  2005cites this paper
• Cholecystokinin binding sites in the rat forebrain: effects of acute and chronic methamphetamine administration

  2005cites this paper
• D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine

  2005cites this paper
• Effect of daily dose of chronic haloperidol and chronic apomorphine on behavioral hypersensitivity in the rat

  2004cites this paper
• Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.

  2004cites this paper
• Differential effects of chronic treatment with chlorpromazine versus cocaine on behavioral responsiveness to nigral GABA receptor stimulation

  2004cites this paper
• Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization

  2004cites this paper
• The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats

  2001cites this paper
• Nature of the working memory deficit in fragile-X syndrome.

  2000cites this paper
• Birth insult increases amphetamine-induced behavioral responses in the adult rat.

  1998cites this paper
• Amphetamine sensitization augments amphetamine-induced Fos expression in the lateral habenula.

  1997cites this paper
• Effect of methamphetamine and dopamine receptor antagonists on cholecystokininlike immunoreactivity in the rat medial prefrontal cortex.

  1997cites this paper
• Amphetamine sensitization enhances regional c-fos expression produced by conditioned fear.

  1997cites this paper
• In-vivo-Charakterisierung des zentralen dopaminergen Systems bei Schizophrenie mit Hilfe der Positronen-Emissionstomographie (PET)

  1996cites this paper
• The Effects of a Selective cAMP Phosphodiesterase Inhibitor, Rolipram, on Methamphetamine-Induced Behavior

  1995cites this paper
• Enhanced stress-induced dopamine release in the prefrontal cortex of amphetamine-sensitized rats.

  1993cites this paper
• Autoradiographic localization of CCK-8 binding sites in the rat brain: effects of chronic methamphetamine administration on these sites.

  1993cites this paper
• Persistent supersensitivity of sigma receptors develops during repeated methamphetamine treatment.

  1992cites this paper
• Lack of Effect of Haloperidol or Methamphetamine Treatment on the mRNA Levels of Two Dopamine D, Receptor Isoforms in Rat Brain

  1992cites this paper
• Sigma (sigma) antagonist BMY 14802 prevents methamphetamine-induced sensitization.

  1992cites this paper
• Persistent supersensitivity of σ receptors develops during repeated methamphetamine treatment

  1992cites this paper
• Subchronic methamphetamine treatment enhances ouabain-induced striatal dopamine efflux in vivo.

  1992cites this paper
• Mesocorticolimbic dopaminergic network: functional and regulatory roles.

  1991cites this paper
• Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis.

  1991cites this paper
• Effects of chronic methamphetamine treatment on the binding parameters of [3H]SCH 23390, a selective D1-dopamine receptor ligand, in the rat brain.

  1990cites this paper
• Does kindling model anything clinically relevant?

  1990cites this paper
• The effects of chronic cocaine administration on brain neurotransmitter receptors

  1990cites this paper
• Dopamine Receptor Changes During Chronic Drug Administration

  1989cites this paper
• Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo.

  1989cites this paper
• Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studied by in vivo intracerebral dialysis.

  1989cites this paper
• Chlordiazepoxide alters intravenous cocaine self-administration in rats.

  1989cites this paper
• Regulation of Dopamine Release by the Autoreceptor after Repeated Methamphetamine Treatment in Rats: An Intracerebral Dialysis Study

  1988cites this paper
• Biological studies in schizophrenia.

  1987cites this paper
• Effects of acute and long-term treatment with amphetamine on evoked responses and long-term potentiation in the dentate gyrus of anesthetized rats.

  1987cites this paper
• Enhancement of ambulation-increasing effect produced by repeated administration of methamphetamine in rats and neurochemical changes in catecholaminergic neurons.

  1987cites this paper
• The absolute density of neurotransmitter receptors in the brain. Example for dopamine receptors.

  1987cites this paper
• Haloperidol prevents the methamphetamine-induced apomorphine subsensitivity of dopamine metabolism in rat striatum.

  1987cites this paper
• 17β Estradiol-induced increase in brain dopamine D-2 receptor: Antagonism by MIF-1

  1987cites this paper
• Acute exacerbation of methamphetamine psychosis and lasting dopaminergic supersensitivity--a clinical survey.

  1986cites this paper
• Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.

  1986cites this paper
• Morphological changes in rat striatal boutons after chronic methamphetamine and haloperidol treatment.

  1986cites this paper
• The Pathogenesis of Tourette Syndrome

  1986cites this paper
• Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.

  1986cites this paper
• Subchronic methamphetamine treatment selectively attenuates apomorphine-induced decrease in 3,4-dihydroxyphenylacetic acid level in mesolimbic dopaminergic regions.

  1985cites this paper
• The kindling phenomenon and a clinical application: the procaine test.

  1985cites this paper
• Neural plasticity in schizophrenia.

  1985cites this paper
• Mesolimbic and striatal dopamine receptor supersensitivity: prophylactic and reversal effects of L-prolyl-L-leucyl-glycinamide (PLG).

  1985cites this paper
• Differential changes in central serotonin and dopamine receptors in spontaneous hypertensive rats.

  1984cites this paper
• Dopamine Receptor Parameters Detected by [3H]Spiperone Depend on Tissue Concentration: Analysis and Examples

  1984cites this paper
• Reduction of 3H-kainic acid binding in rat cerebral cortex by chronic methamphetamine administration.

  1984cites this paper
• Chapter 16 – DOPAMINE RECEPTORS IN BRAIN

  1984cites this paper
• A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

  1984cites this paper
• Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.

  1983cites this paper
• Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment.

  1983cites this paper
• Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.

  1982cites this paper